• 

  BDNF Mediates Neuroprotection against Oxygen-Glucose Deprivation by the Cardiac Glycoside Oleandrin.

  BDNF Mediates Neuroprotection against Oxygen-Glucose Deprivation by the Cardiac Glycoside Oleandrin.

BDNF Mediates Neuroprotection against Oxygen-Glucose Deprivation by the Cardiac Glycoside Oleandrin.

[email protected]2023-12-04T17:18:42-06:00

Read More

Comments Off on BDNF Mediates Neuroprotection against Oxygen-Glucose Deprivation by the Cardiac Glycoside Oleandrin.

• 

  Presentation Abstract: PBI-05204, a supercritical CO2 extract of Nerium oleander, inhibits the growth of human pancreatic cancer in a Panc-1 orthotopic model by down-regulation of PI3k/mTOR pathways.

  Presentation Abstract: PBI-05204, a supercritical CO2 extract of Nerium oleander, inhibits the growth of human pancreatic cancer in a Panc-1 orthotopic model by down-regulation of PI3k/mTOR pathways.

Presentation Abstract: PBI-05204, a supercritical CO2 extract of Nerium oleander, inhibits the growth of human pancreatic cancer in a Panc-1 orthotopic model by down-regulation of PI3k/mTOR pathways.

[email protected]2023-12-04T17:18:47-06:00

Read More

Comments Off on Presentation Abstract: PBI-05204, a supercritical CO2 extract of Nerium oleander, inhibits the growth of human pancreatic cancer in a Panc-1 orthotopic model by down-regulation of PI3k/mTOR pathways.

• 

  Presentation Abstract: PBI-05204, a supercritical CO2 extract of Nerium oleander, inhibits the growth of human pancreatic cancer in a Panc-1 orthotopic model by down-regulation of PI3k/mTOR pathways.

  Presentation Abstract: PBI-05204, a supercritical CO2 extract of Nerium oleander, inhibits the growth of human pancreatic cancer in a Panc-1 orthotopic model by down-regulation of PI3k/mTOR pathways.

Presentation Abstract: PBI-05204, a supercritical CO2 extract of Nerium oleander, inhibits the growth of human pancreatic cancer in a Panc-1 orthotopic model by down-regulation of PI3k/mTOR pathways.

[email protected]2023-12-04T17:18:51-06:00

Read More

Comments Off on Presentation Abstract: PBI-05204, a supercritical CO2 extract of Nerium oleander, inhibits the growth of human pancreatic cancer in a Panc-1 orthotopic model by down-regulation of PI3k/mTOR pathways.

• 

  Nerium oleander derived cardiac glycoside oleandrin is a novel inhibitor of HIV infectivity.

  Nerium oleander derived cardiac glycoside oleandrin is a novel inhibitor of HIV infectivity.

Nerium oleander derived cardiac glycoside oleandrin is a novel inhibitor of HIV infectivity.

[email protected]2023-12-04T17:18:55-06:00

Read More

Comments Off on Nerium oleander derived cardiac glycoside oleandrin is a novel inhibitor of HIV infectivity.

• 

  Digoxin and ouabain induce the efflux of cholesterol via liver X receptor signalling and the synthesis of ATP in cardiomyocytes.

  Digoxin and ouabain induce the efflux of cholesterol via liver X receptor signalling and the synthesis of ATP in cardiomyocytes.

Digoxin and ouabain induce the efflux of cholesterol via liver X receptor signalling and the synthesis of ATP in cardiomyocytes.

[email protected]2023-12-04T17:19:53-06:00

Read More

Comments Off on Digoxin and ouabain induce the efflux of cholesterol via liver X receptor signalling and the synthesis of ATP in cardiomyocytes.

• 

  Cellular location and expression of Na+, K+-ATPase α subunits affect the anti-proliferative activity of oleandrin.

  Cellular location and expression of Na+, K+-ATPase α subunits affect the anti-proliferative activity of oleandrin.

Cellular location and expression of Na+, K+-ATPase α subunits affect the anti-proliferative activity of oleandrin.

[email protected]2023-12-04T17:18:59-06:00

Read More

Comments Off on Cellular location and expression of Na+, K+-ATPase α subunits affect the anti-proliferative activity of oleandrin.

• 

  Phase I Clinical Trial of PBI-05204 successfully completed at M. D. Anderson Cancer Center.

  Phase I Clinical Trial of PBI-05204 successfully completed at M. D. Anderson Cancer Center.

Phase I Clinical Trial of PBI-05204 successfully completed at M. D. Anderson Cancer Center.

[email protected]2023-12-04T17:20:14-06:00

Read More

Comments Off on Phase I Clinical Trial of PBI-05204 successfully completed at M. D. Anderson Cancer Center.

• 

  Publication: Human tumor cell sensitivity to oleandrin is dependent on relative expression of Na+, K+ -ATPase subunits.

  Publication: Human tumor cell sensitivity to oleandrin is dependent on relative expression of Na+, K+ -ATPase subunits.

Publication: Human tumor cell sensitivity to oleandrin is dependent on relative expression of Na+, K+ -ATPase subunits.

[email protected]2023-12-04T17:19:04-06:00

Read More

Comments Off on Publication: Human tumor cell sensitivity to oleandrin is dependent on relative expression of Na+, K+ -ATPase subunits.

• 

  Society of Integrative Oncology (SIO) International Conference- comprehensive poster presentation with discussion.

  Society of Integrative Oncology (SIO) International Conference- comprehensive poster presentation with discussion.

Society of Integrative Oncology (SIO) International Conference- comprehensive poster presentation with discussion.

[email protected]2023-12-04T17:19:09-06:00

Read More

Comments Off on Society of Integrative Oncology (SIO) International Conference- comprehensive poster presentation with discussion.

• 

  Update on Phase I trial of PBI-05204: ASCO annual meeting poster presentation with discussion.

  Update on Phase I trial of PBI-05204: ASCO annual meeting poster presentation with discussion.

Update on Phase I trial of PBI-05204: ASCO annual meeting poster presentation with discussion.

[email protected]2023-12-04T17:19:13-06:00

Read More

Comments Off on Update on Phase I trial of PBI-05204: ASCO annual meeting poster presentation with discussion.